5 unchanged sentences
Rule 10b5-1 under the Exchange Act provides an affirmative defense that enables directors and officers to prearrange transactions in our securities in a manner that avoids concerns about initiating transactions while in possession of material nonpublic information.
−Removed: During the quarterly period covered by this report, Erick Lucera , our Chief Financial Officer , entered into a Rule 10b5-1 trading arrangement that is intended to qualify as an “eligible sell-to-cover transaction” (as described in Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act).
−Removed: This sell-to-cover arrangement, which was adopted on May 12, 2023, applies to restricted stock units (“RSUs”), whether vesting is based on the passage of time and/or the achievement of performance goals, granted on his start date, May 17, 2023 , and any RSUs that may be granted from time to time thereafter (other than those which by their terms require us to withhold shares for tax withholding obligations in connection with vesting and settlement).
+Added: During the quarterly period covered by this report, Linda C.
+Added: Burkly, Ph.D.
+Added: , our Chief Scientific Officer , entered into a Rule 10b5-1 trading arrangement that is intended to qualify as an “eligible sell-to-cover transaction” (as described in Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act).
+Added: This sell-to-cover arrangement, which was adopted on July 3, 2023 , applies to restricted stock units (“RSUs”), whether vesting is based on the passage of time and/or the achievement of performance goals, granted on her start date, July 24, 2023, and any RSUs that may be granted from time to time thereafter (other than those which by their terms require us to withhold shares for tax withholding obligations in connection with vesting and settlement).
This arrangement provides for the automatic sale of shares of our common stock that would otherwise be issuable on each settlement date of a covered RSU in an amount necessary to satisfy the applicable withholding obligation, with the proceeds of the sale delivered to us in satisfaction of the applicable withholding obligation.
2 unchanged sentences
Exhibit Index
−Removed: Description of Exhibit
−Removed: Employment Offer Letter, dated May 12, 2023, between the Registrant and Erick Lucera.
−Removed: Separation Agreement, dated May 16, 2023, between the Registrant and Michelle Robertson.
+Added: Number Description of Exhibit
10.1 Employment Offer Letter, dated July 3, 2023, between the Registrant and Linda C.
+Added: Burkly (incorporated by reference to Exhibit 10.3 to the Company's Quarterly Report on Form 10-Q (File No.
+Added: 001-37687) filed with the Securities and Exchange Commission on August 2, 2023)
+Added: 10.2* Separation Agreement, dated October 6, 2023 between the Registrant and Bruce Eaton
31.1* Rule 13a-14(a) Certification of Principal Executive Officer
1 unchanged sentence
32.1+ Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C.
−Removed: The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline XBRL (eXtensible Business Reporting Language):
+Added: 101* The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in Inline XBRL (eXtensible Business Reporting Language):
(i) Condensed Consolidated Balance Sheets (unaudited), (ii) Condensed Consolidated Statements of Operations (unaudited), (iii) Condensed Consolidated Statements of Comprehensive Loss (unaudited), (iv) Condensed Consolidated Statements of Stockholders’ Equity (unaudited), (v) Condensed Consolidated Statements of Cash Flows (unaudited) and (vi) Notes to Condensed Consolidated Financial Statements (unaudited), tagged as blocks of text and including detailed tags.
−Removed: The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline XBRL.
+Added: 104* The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in Inline XBRL.
* Filed herewith
3 unchanged sentences
EDITAS MEDICINE, INC.
−Removed: August 2, 2023
+Added: November 3, 2023
/s/ Erick Lucera
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.